A carregar...
Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View
Despite considerable psychotherapeutic advancement since the discovery of chlorpromazine, almost one third of patients with schizophrenia remain resistant to dopamine-blocking antipsychotics, and continue to be exposed to unwanted and often disabling side effects, but little if any clinical benefit....
Na minha lista:
| Publicado no: | Front Psychiatry |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6735262/ https://ncbi.nlm.nih.gov/pubmed/31551822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2019.00601 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|